EUVIMEDEUVIMED entdecken
Crossref

Superficial Neurocristic EWSR1::FLI1 Fusion Tumor: A Distinctive, Clinically Indolent, S100 Protein/SOX10-Positive Neoplasm

Andrew L Folpe, Michael T Tetzlaff, Steven D Billings, Jorge Torres-Mora, Alexander David Borowsky, Teresa C Santiago, Baptiste Ameline, Daniel Baumhoer

Modern Pathology · 2024-08 · 37 (8) · 100537

DOI: 10.1016/j.modpat.2024.100537 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Modern Pathology, 2024-08. Verfasst von Andrew L Folpe und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, Minnesota. Electronic address: folpe.andrew@mayo.edu. Hauptthemen laut MEDLINE: Biomarkers, Tumor, Homeobox Protein Nkx-2.2, Oncogene Proteins, Fusion, S100 Proteins. Die Arbeit wurde bisher 35-mal zitiert (Crossref) und nennt 61 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Biomarkers, TumorHomeobox Protein Nkx-2.2Oncogene Proteins, FusionS100 ProteinsSkin NeoplasmsSOXE Transcription FactorsAdultAgedFemaleHumansMaleMiddle AgedYoung AdultDNA MethylationHomeodomain ProteinsImmunohistochemistryNuclear ProteinsProto-Oncogene Protein c-fli-1RNA-Binding Protein EWSRNA-Binding ProteinsSarcoma, EwingTranscription FactorsZebrafish Proteins

Stichwörter der Autor:innen

EWSR1::FLI1Ewing sarcomacutaneous neoplasmsimmunohistochemistrymethylation profilingnext-generation sequencing

Substanzen

Biomarkers, TumorHomeobox Protein Nkx-2.2Homeodomain ProteinsNuclear ProteinsOncogene Proteins, FusionProto-Oncogene Protein c-fli-1RNA-Binding Protein EWSRNA-Binding ProteinsS100 ProteinsSOXE Transcription Factors

Autor:innen und Institutionen

  • Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, Minnesota. Electronic address: folpe.andrew@mayo.edu.
  • Departments of Pathology and Dermatology, University of California-San Francisco, San Francisco, California.
  • Department of Pathology, Cleveland Clinic Foundation, Cleveland, Ohio.
  • Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, Minnesota.
  • University of California-Davis Health System, Davis, California.
  • St. Jude Children's Research Hospital, Memphis, Tennessee.

Zitieren

APA

Folpe, A. L., Tetzlaff, M. T., Billings, S. D., Torres-Mora, J., Borowsky, A. D., Santiago, T. C., Ameline, B., & Baumhoer, D. (2024). Superficial Neurocristic EWSR1::FLI1 Fusion Tumor: A Distinctive, Clinically Indolent, S100 Protein/SOX10-Positive Neoplasm. Modern Pathology, 37(8), 100537. https://doi.org/10.1016/j.modpat.2024.100537

Vancouver

Folpe AL, Tetzlaff MT, Billings SD, Torres-Mora J, Borowsky AD, Santiago TC, et al. Superficial Neurocristic EWSR1::FLI1 Fusion Tumor: A Distinctive, Clinically Indolent, S100 Protein/SOX10-Positive Neoplasm. Modern Pathology. 2024;37(8):100537. doi:10.1016/j.modpat.2024.100537

BibTeX
@article{Folpe2024,
  author = {Folpe, Andrew L and Tetzlaff, Michael T and Billings, Steven D and Torres-Mora, Jorge and Borowsky, Alexander David and Santiago, Teresa C and Ameline, Baptiste and Baumhoer, Daniel},
  title = {Superficial Neurocristic EWSR1::FLI1 Fusion Tumor: A Distinctive, Clinically Indolent, S100 Protein/SOX10-Positive Neoplasm},
  journal = {Modern Pathology},
  year = {2024},
  volume = {37},
  number = {8},
  pages = {100537},
  doi = {10.1016/j.modpat.2024.100537}
}
Kostenlos starten →